Royal Bank Of Canada Igm Biosciences, Inc. Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 20,049 shares of IGMS stock, worth $25,662. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,049
Previous 42,078
52.35%
Holding current value
$25,662
Previous $695,000
82.45%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding IGMS
# of Institutions
85Shares Held
19.4MCall Options Held
61.3KPut Options Held
36.7K-
Baker Bros. Advisors LP New York, NY4.09MShares$5.24 Million0.28% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.57MShares$4.57 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY3.33MShares$4.26 Million0.9% of portfolio
-
Redmile Group, LLC San Francisco, CA2.95MShares$3.78 Million1.41% of portfolio
-
Goldman Sachs Group Inc New York, NY978KShares$1.25 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $37.1M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...